Literature DB >> 3055413

Antithrombin Oslo: type Ib classification of the first reported antithrombin-deficient family, with a review of hereditary antithrombin variants.

M B Hultin1, J McKay, U Abildgaard.   

Abstract

Patients with classical antithrombin deficiency (Type I) from seven unrelated kindreds were studied by crossed immunoelectrophoresis of plasma in the presence and absence of heparin. The only abnormal pattern was found in the kindred first reported by Egeberg in 1965. An abnormal cathodal peak of antithrombin antigen was found in the presence, but not the absence, of heparin in the first dimension gel. We have named this variant antithrombin Oslo. Such evidence of an abnormal protein, despite equivalent low levels of antithrombin antigen and activity, has been denoted previously by Sas as Type Ib deficiency. In the context of this new report, we review the literature to date on 33 other variants of the Types Ib, II and III subclassifications with a discussion of the value of the classification scheme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055413

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Pleiotropic effects of antithrombin strand 1C substitution mutations.

Authors:  D A Lane; R J Olds; J Conard; M Boisclair; S C Bock; M Hultin; U Abildgaard; H Ireland; E Thompson; G Sas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  Thrombophilia: how far should a clotter be investigated?

Authors:  I D Walker
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

3.  Antithrombin III: summary of first database update.

Authors:  D A Lane; R J Olds; S L Thein
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

4.  Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.

Authors:  P Molho-Sabatier; M Aiach; I Gaillard; J N Fiessinger; A M Fischer; G Chadeuf; E Clauser
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  To be or not to be a case of heparin resistance.

Authors:  Jibran Durrani; Faizan Malik; Naveed Ali; Syed Imran Mustafa Jafri
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.